For research use only. Not for therapeutic Use.
Macitentan-d4 is a deuterium labeled Sulfamethoxazole. Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].
| Catalog Number | S000294 |
| CAS Number | 1258428-05-5 |
| Molecular Formula | C19H16D4Br2N6O4S |
| Purity | ≥95% |
| Reference | [1]. Corallo C, et al. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. Arthritis Res Ther. 2016 Oct 6;18(1):228. |
